148 related articles for article (PubMed ID: 33015935)
1. Role of physician density in predicting stage and survival for head and neck squamous cell carcinoma.
Gadkaree SK; McCarty JC; Feng AL; Siu JM; Burks CA; Deschler DG; Richmon JD; Varvares MA; Bergmark RW
Head Neck; 2021 Feb; 43(2):438-448. PubMed ID: 33015935
[TBL] [Abstract][Full Text] [Related]
2. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
3. Survival differences among American Indians/Alaska Natives with head and neck squamous cell carcinoma.
Dwojak SM; Sequist TD; Emerick K; Deschler DG
Head Neck; 2013 Aug; 35(8):1114-8. PubMed ID: 22887354
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare Patients.
Hansen CC; Egleston B; Leachman BK; Churilla TM; DeMora L; Ebersole B; Bauman JR; Liu JC; Ridge JA; Galloway TJ
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1136-1146. PubMed ID: 33090191
[TBL] [Abstract][Full Text] [Related]
5. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic factors and survival in patients with non-metastatic head and neck squamous cell carcinoma.
Xu C; Chen YP; Liu X; Tang LL; Chen L; Mao YP; Zhang Y; Guo R; Zhou GQ; Li WF; Lin AH; Sun Y; Ma J
Cancer Sci; 2017 Jun; 108(6):1253-1262. PubMed ID: 28383806
[TBL] [Abstract][Full Text] [Related]
7. Patient Choice of Nonsurgical Treatment Contributes to Disparities in Head and Neck Squamous Cell Carcinoma.
Parhar HS; Anderson DW; Janjua AS; Durham JS; Prisman E
Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1057-1064. PubMed ID: 29436282
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
9. Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare Analysis.
Vyfhuis MAL; Suzuki I; Bentzen SM; Cullen KJ; Goloubeva OG
Oncologist; 2021 Jul; 26(7):579-587. PubMed ID: 33783061
[TBL] [Abstract][Full Text] [Related]
10. The impact of the pandemic on the presentation and treatment of head and neck squamous cell carcinoma at a county hospital.
Allen DZ; Ahmad JG; McKee SP; Suarez N; Basmaci UN; Alava I
Am J Otolaryngol; 2024; 45(1):104103. PubMed ID: 37988796
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME
ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465
[TBL] [Abstract][Full Text] [Related]
12. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma.
Sineshaw HM; Ellis MA; Yabroff KR; Han X; Jemal A; Day TA; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):247-255. PubMed ID: 31944232
[TBL] [Abstract][Full Text] [Related]
13. Second primary lung malignancy following head and neck squamous cell carcinoma.
Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
[TBL] [Abstract][Full Text] [Related]
14. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
[TBL] [Abstract][Full Text] [Related]
15. Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data.
Bean MB; Liu Y; Jiang R; Steuer CE; Patel M; McDonald MW; Higgins KA; Beitler JJ; Shin DM; Saba NF
Oncologist; 2019 Dec; 24(12):1562-1569. PubMed ID: 31391295
[TBL] [Abstract][Full Text] [Related]
16. The "Medicare effect" on head and neck cancer diagnosis and survival.
Smith JB; Jayanth P; Hong SA; Simpson MC; Massa ST
Head Neck; 2023 Jul; 45(7):1663-1675. PubMed ID: 37096786
[TBL] [Abstract][Full Text] [Related]
17. Survival Outcomes in Early Stage Laryngeal Cancer.
Megwalu UC; Panossian H
Anticancer Res; 2016 Jun; 36(6):2903-7. PubMed ID: 27272804
[TBL] [Abstract][Full Text] [Related]
18. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
[TBL] [Abstract][Full Text] [Related]
20. The impact of the multidisciplinary tumor board on head and neck cancer outcomes.
Liu JC; Kaplon A; Blackman E; Miyamoto C; Savior D; Ragin C
Laryngoscope; 2020 Apr; 130(4):946-950. PubMed ID: 31095740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
